Will Herrington's Avatar

Will Herrington

@willkidney.bsky.social

Kidney doctor and professor of clinical trials and epidemiology of kidney disease at CTSU, University of Oxford. EMPA-KIDNEY & EASi-KIDNEY CI. Needs to be large & randomized (or a bike!)

133 Followers  |  296 Following  |  7 Posts  |  Joined: 26.01.2025  |  1.6486

Latest posts by willkidney.bsky.social on Bluesky

Almost all u need 2 know about the remarkable clinical effects of #SGLT2i on the kidney in a wide ranging IPD metaanalysis (covers effects by albuminuria, predicted eGFR dip and novel exploratory eGFR slope methods). Please do read it! @oxpop.bsky.social @martinlandray.bsky.social

12.10.2025 20:46 β€” πŸ‘ 3    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

3000th #EASi-KIDNEY pt screened. The aim is to accelerate & maximize recruited b4 Xmas πŸŽ„ πŸ’ Final target=11000 randomized! Nephrology showing we can recruit #CKD rapidly & at scale. Thank you for everyone’s perseverance during setup. 🀩 ⁦β€ͺ⁦β€ͺ@Oxford_NDPH‬⁩ ⁦β€ͺ@DCRINews‬⁩

20.08.2025 06:31 β€” πŸ‘ 4    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Petition: Ban travel insurance premium hikes & refusals for people in clinical trials Ban travel insurance companies vastly increasing premiums, or refusal to cover people who partake in clinical trials, which may make it impossible for them to travel without resulting in substantial a...

We don’t want travel insurance companies to punish trial volunteers - the treatments we all rely upon are thanks to volunteers from the past, present and future. Worth everyone subsiding. Agreed? If so, please sign below….! petition.parliament.uk/petitions/72...

21.07.2025 13:37 β€” πŸ‘ 4    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
An application of the MR-Horse method to reduce selection bias in genome-wide association studies of disease progression - European Journal of Human Genetics European Journal of Human Genetics - An application of the MR-Horse method to reduce selection bias in genome-wide association studies of disease progression

Collider bias affects genome-wide association studies (GWAS) of disease progression phenotypes. @willkidney.bsky.social ney.bsky.social
This study reports a method to reduce this bias. Find out more ⬇️
www.nature.com/articles/s41...

18.06.2025 05:06 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

@ukkidney.org anaemia in #CKD guidelines head-to-head with @kdigo.org draft statements at #UKKW25 debate in Bournemouth. Exact Hb threshold may be as low as 9 g/dL (or as high as 10.5!) DW vs SB.

12.06.2025 09:23 β€” πŸ‘ 3    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image Post image

🌍 History made! For the first time, kidney care is on the global health agenda. #WHA78 adopted a landmark resolution recognizing kidney health in the fight against #NCDs.

πŸ‘ Thanks to Guatemala and the global kidney community for making this possible!

#KidneyHealthMatters

23.05.2025 14:27 β€” πŸ‘ 13    πŸ” 6    πŸ’¬ 1    πŸ“Œ 5
Post image

In 1978, the idea that large randomized trials was born in this important Richard Peto paper….Rory Collins telling the story of CTSU @oxpop.bsky.social (following Rona Smith’s talk describing large dialysis trial in progress 47 years later!)

16.05.2025 08:29 β€” πŸ‘ 5    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

#EASi-KIDNEY recruitment building globally! Nephrology aiming to show the world we can complete mega-trials (target 11,000 recruits). @oxpop.bsky.social Parminder Judge presenting to the UK collaboration today thanking sites for pushing through the startup processes (more at www.easikidney.org)

16.05.2025 08:27 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Interesting preliminary data on SGLT2i in ADPKD on background of tolvaptan. Worthy of larger trials….

13.05.2025 03:47 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

@willkidney is following 20 prominent accounts